Epidemiology of cataract: Accomplishments over 25 years and future directions

Ophthalmic Epidemiology

Volumn 14, Issue 4, 2007, Pages 173-178

  West, Sheila ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Cataract; Epidemiology; Risk factor

Indexed keywords

CORTICOSTEROID;

AGING; BLINDNESS; CATARACT; CATARACT EXTRACTION; CONFERENCE PAPER; DIABETES MELLITUS; EPIDEMIOLOGICAL DATA; FUTUROLOGY; GENETIC SUSCEPTIBILITY; HUMAN; INCIDENCE; MORTALITY; OXIDATIVE STRESS; PHENOTYPE; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

CATARACT; CATARACT EXTRACTION; EPIDEMIOLOGIC STUDIES; HUMANS; PHENOTYPE;

EID: 34848892120     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.1080/09286580701423151     Document Type: Conference Paper

References (83)

1. Resnikoff S, Pascolini D, D'etyale D, et al. Global data on visual impairment in the year 2002. Bull World Health Org. 2004;82:844-851.
2. Chylack LT, Leske MC, Sperduto R, et al. Lens opacity classification system. Arch Ophthalmol. 1988;106:330-334.
3. West SK, Rosenthal F, Newland HS, Taylor HR. Use of photographic techniques to grade nuclear cataracts. Invest Ophthal Vis Sci. 1988;29:73-77.
4. Sparrow J, Born AJ, Brown NA, Ayliffe W, Hill AR. The Oxford Clinical Cataract Classification and Grading System. Int Ophthalmol. 1986;9:207-225.
5. Taylor HR, West SK. The clinical grading of lens opacities. Aust New Zeal J Ophthalmol. 1989;17:81-86.
6. Klein BEK, Klein R, Linton K, et al. Assessment of cataract from photographs in the Beaver Dam Eye Study. Ophthalmology. 1990;97:1428-1433.
7. West SK, Munoz B, Schein OD, Duncan DD, Rubin GS. Racial differences in lens opacities: the Salisbury Eye Evaluation (SEE) project. Am J Epidemiol. 1998;148:1033-1039.
8. Leske MC, Connell AM, Wu SY, Hyman L, Schachat A. Prevalence of lens opacities in the Barbados Eye Study. Arch Ophthalmol. 1997;115:105-111.
9. Leske MC, Wu SY, Nemesure B, Yang L, Hennis A; Barbados Eye Studies Group. Nine-year incidence of lens opacities in the Barbados Eye Studies. Ophthalmology. 2004;111:483-490.
10. Varma R, Torres M, Los Angeles Latino Eye Study Group. Prevalence of lens opacities in Latinos: the Los Angeles Latino Eye Study. Ophthalmology. 2004;111:1449-1456.
11. Seah SK, Wong TY, Foster PJ, Ng TP, Johnson GJ. Prevalence of lens opacity in Chinese residents of Singapore: the Tanjong Pagar survey. Ophthalmology. 2002;109:2058-2064.
12. Tsai SY, Hsu WM, Cheng CY, Liu JH, Chou P. Epidemiologic study of age-related cataracts among an elderly Chinese population in Shih-Pai, Taiwan. Ophthalmology. 2003;110:1089-1095.
13. West SK, Valmadrid CT. Epidemiology of risk factors for age related cataract. Surv Ophthalmol. 1995;39:323-334.
14. Abraham AG, Congdon NC, Gower EW. The new epidemiology of cataract. Ophthalmol Clin N Amer. 2006;19:415-425.
15. SD Varma. Aldose reductase and the etiology of diabetic cataract. Curr Topics Eye Res. 1970;3:91.
16. Biswas S, Harris F, Singh J, Phoenix DS. Role of calpains in diabetes mellitus-induced cataractogenesis. Mol Cell Biochem. 2004;261:151-159.
17. Klein BE, Klein R, Lee KE. Diabetes, cardiovascular disease, selected cardiovascular risk factors and 5 year incidence of age related cataract and progression of lens opacities. Am J Ophthalmol. 1998;126:782-790.
18. Hennis A, Wu SY, Nemesure B, et al. Risk factors for incident cortical and posterior sub-capsular lens opacities in the Barbados Eye Study. Arch Ophthalmol. 2004;122:525-530.
19. West SK, Duncan DD, Munoz B, et al. Sunlight exposure and risk of lens opacities in a population-based study: The Salisbury Eye Evaluation Project. J Am Med Assoc. 1998;280:714-718.
20. Saxena S, Mitchell P, Rochtchina E. Five year incidence of cataract in older persons with diabetes and pre-diabetes. Ophthalmic Epi. 2004;11:271-277.
21. Klein BEK, Klein R, Moss SE. Prevalence of cataract in a population based study of persons with diabetes mellitus. Ophthalmology. 1990;92:1191-1196.
22. Leske MC, Wu SY, Hennis A, et al. Diabetes, hypertension, and central obesity as cataract risk factors in a black population. The Barbados Eye Study. Ophthalmology. 1999;106:35-41.
23. Hollows F, Moran D. Cataract-the ultraviolet risk factor Lancet 1981;2:1249-1250
24. Brilliant LB, Grasset NC, Pokhrel RP, Kolstad A, Lepkowski JM, Brilliant GE, Hawks WN, Pararajasegaram R. Associations among cataract prevalence, sunlight hours, and altitude in the Himalayas. Am J Epidemiol. 1983;118:250-264.
25. Pitts DG. Ocular Ultraviolet effects from 295nm to 335 nm in the rabbit eye. US Dept Health, Education, and Welfare, Center for Disease Control, National Institute for Occupational Safety and Health, DHEW (NIOSH)Publ No 77-130. 1976 pp1-50.
26. Duncan DD, Schneider W, West KJ, Kirkpatrick SJ, West SK. The development of personal dosimeters for use in the visible and ultraviolet wavelengths regions. The Salisbury Eye Evaluation Team. Photochem Photobiol. 1995;62:94-100.
27. Duncan DD, Munoz B, Bandeen Roche K, West SK. Visible and ultraviolet-B ocular-ambient exposure ratios for a general population. Salisbury Eye Evaluation Project. Invest Ophthalmol Vis Sci. 1997;38:1003-1011.
28. Duncan DD, Munoz B, Bandeen-Roche K, West SK. Assessment of ocular exposure to ultraviolet-B for population studies: Salisbury Eye Evaluation Project Photochem Photobiol. 1997;66:701-709.
29. Taylor HR, West SK, Rosenthal FS, Munoz B, Newland HS, Abbey H, Emmett EA. Effect of ultraviolet radiation on cataract formation. New Engl J Med. 1988 1;319:1429-33.
30. West SK, Longstreth JD, Munoz BE, Pitcher HM, Duncan DD. Model of risk of cortical cataract in the US population with exposure to increased ultraviolet radiation due to stratospheric ozone depletion. Am J Epidemiol. 2005;162:1080-1088.
31. http://www.epa.gov/ne/sunwise/index.html,
32. http://www.sunsmart.com.au/.
33. http://www.hc-sc.gc.ca/hl-vs/securit/sports/sun-sol/index e.html
34. Shui YB, Fu JJ, Garcia C, et al. Oxygen distribution in the rabbit eye and oxygen consumption by the lens. Invest Ophthalmol Vis Sci. 2006;47:1571-1580.
35. Wu SY, Leske MC. Antioxidants and cataract formation: a summary review. Int Ophthalmol Clin. 2000;40:71-81.
36. McNeil JJ, Robinson L, Tikellis G, et al. Vitamin E supplementation and cataract. Randomized controlled trial. Ophthalmology. 2004;111:75-84.
37. Age Related Eye disease Study Group. A randomized placebo controlled clinical trial of high dose supplementation with vitamins C and E and beta carotene for age related cataract and vision loss: AREDS report no 9; Arch Ophthalmol. 2001;119:1439-1452.
38. Gritz DC, Srinivasan M, Smith SD, et al. The antioxidant in prevention of cataract study: effects of antioxidant supplements on cataract progression in South India. Br J Ophthalmol. 2006;90:847-851.
39. Holekamp NM, Shui YB, Beebe DC. Vitrectomy surgery increases oxygen exposure to the lens: a possible mechanism for nuclear cataract formation. Am J Ophthalmol. 2005;139:302-310.
40. Harocopos GJ, Shui YB, McKinnon M, et al. Importance of vitreous liquefaction in age related cataract. Invest Ophthalmol Vis Sci. 2004;45:77-85.
41. Freeman EE, Munoz B, Schein OD, West SK Hormone replacement therapy and lens opacities: the Salisbury Eye Evaluation Project. Arch Ophthalmol. 2001;119:1687-1692.
42. Klein BE, Klein R, Ritter LL. Is there evidence of an estrogen effect on age-related lens opacities? The Beaver Dam Eye Study. Arch Ophthalmol. 1994;112:85-91.
43. Freeman EE, Munoz B, Schein OD, West SK. Incidence and progression of lens opacities: effect of hormone replacement therapy and reproductive factors. Epidemiology. 2004;15:451-457.
44. Klein BE, Klein R, Lee KE. Reproductive exposures, incident age related cataracts, and age-related maculopathy in women: the Beaver Dam Eye study. Am J Ophthalmol. 2000;130:322-326.
45. Klein BE, Klein R, Lee KK, Grady LM. Statin use and incident nuclear cataract. J Am Med Assoc. 2006;295:2752-2758.
46. Leske MC. Nuclear cataract: do statins reduce risk? Arch Ophthalmol. (commentary) 2007;125:401-402.
47. Cummings RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and risk of cataracts. New Eng J Med. 1997;337:8-14.
48. Leske MC, Wu SY, Nemesure B et al. Risk factors for incident nuclear opacities. Ophthalmology. 2002;109:1303-1308.
49. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268-1279.
50. Herman DC, Gordon MO, Beiser JA, et al. Topical ocular hypotensive medication and lens opacification: evidence from the Ocular Hypertension Treatment Study. Am J Ophthalmol 2006;142: 800-810.
51. West SK, Munoz B, Emmett EA, Taylor HR. Cigarette smoking and risk of nuclear cataract. Arch Ophthalmol. 1989;107:1166-1169.
52. West S, Munoz B, Schein OD, Vitale S, Maguire M, Taylor HR, Bressler NM. Cigarette smoking and risk for progression of nuclear opacities. Arch Ophthalmol. 1995;113:1377-1380.
53. Flaye DE, Sullivan KN, Cullinan TR, et al. Cataract and cigarette smoking. The City Eye Study. Eye 1989;3:379-384.
54. Christen WG, Manson JE, Seddon JM, et al. A prospective study of cigarette smoking and risk of cataract in men. J Am Med Assoc. 1992;268:989-993.
55. Christen WG, Glynn RJ, Ajani UA, et al. Smoking cessation and risk of age related cataract in men. J Am Med Assoc. 2000;284:713-716.
56. US Department of Health and Human Services. 2004 Surgeon General's Report: The Health Consequences of Smoking. Atlanta GA. Centers for Disease Control and Prevention, Office on smoking and health. US government printing Office, Washington DC. 2004 pg 777.
57. Hammond CJ, Snieder H, Spector TD, et al. Genetic and environmental factors in age related nuclear cataracts in monozygotic and dizygotic twins. New Eng J Med. 2000;342:1786-1790.
58. Congdon N, Broman KW, Lai H, et al. Nuclear cataract shows significant familial aggregation in the older population after adjustment for possible shared environmental factors. Invest Ophthalmol Vis Sci. 2004;45:2182-2186.
59. Klein AP, Duggal P, Lee KE, O'Neill JA, Klein R, Bailey-Wilson JE, Klein BE. Polygenic effects and cigarette smoking account for a portion of the familial aggregation of nuclear sclerosis. Am J Epidemiol. 2005;161:707-713.
60. Hammond CJ, Duncan D, Sneider H, et al. The Heritability of age related cortical cataract: The Twin Eye Study. Invest Ophthalmol Vis Sci. 2001;42:601-605.
61. Congdon N, Broman KW, Lai H, et al. Cortical but not posterior sub capsular cataract shows significant familial aggregation in an older population after adjustment for possible shared environmental factors. Ophthalmology. 2005;112:73-77.
62. Sun H, Ma Z, Li Y, et al. Gamma-S crystallin gene (CRYGS) mutation causes dominant progressive cortical cataract in humans. J Med Genet. 2005;42:706-710.
63. Iyengar SK, Klein BE, Klein R, et al. Identification of a major locus for age-related cortical cataract on chromosome 6p12-q12 in the Beaver Dam Eye Study. Proc Natl Acad Sci USA. 2004;101:14485-14490.
64. Limburg H, Foster A, Vaidyanathan K, Murthy GV. Monitoring visual outcome of cataract surgery in India. Bull World Health Org. 1999;77:455-460.
65. Venkata G, Murthy S, Gupta SK, Bachani D, Jose R, John N. Current estimates of Blindness in India. Br. J. Ophthalmol. 2005;89;257-260.
66. Abou-Gareeb I, Lewallen S, Bassett K, Courtright P. Gender and Blindness: a meta analyses of population-based surveys. Ophthalmic Epidemiol. 2001;8:39-56.
67. Marseille E, Brand R. The distribution of cataract surgery services in a public health eye care program in Nepal. Health Policy 1997;42:117-133.
68. Snellingen T, Shrestha BR, Charti MP, Shrestha JK, Upadhyay MP, Pokhrel RP. Socioeconomic barriers to cataract surgery in Nepal: the South Asian cataract management study. Br J Ophthalmol. 1998;82:1424-1428.
69. Lewallen S, Courtright P. Gender and use of cataract surgical services in developing countries. Bull World Health Org. 2002;80:300-303.
70. Dandona L, Dandona R, Naduvilath TJ, McCarty CA, Mandal P, Srinivas M, Nanda A, Rao GN. Population-based assessment of the outcome of cataract surgery in an urban population in southern India. Am J Ophthalmol. 1999;127:650-658.
71. West SK, Munoz B, Schein OD, Duncan DD, Rubin GS. Racial differences in lens opacities: the Salisbury Eye Evaluation (SEE) Project. Am J Epidemiol. 1998;148:1033-1039.
72. Broman AT, Hafiz G, Munoz B, Rodriguez J, Snyder R, Klein R, West SK. Cataract and barriers to cataract surgery in a US Hispanic population: Proyecto VER. Arch Ophthalmol. 2005;123:1231-1236.
73. Zhang X, Saaddine JB, Lee PP, et al. Eye Care in the United States: Dowe deliver to high risk people who can benefit most from it? Arch Ophthalmol. 2007;125:411-418.
74. Schein OD, Katz J, Bass EB, Tielsch JM, Lubomski LH, Feldman MA, Petty BG, Steinberg EP. The value of routine preoperative medical testing before cataract surgery. Study of Medical Testing for Cataract Surgery. New Engl J Med. 2000;342:168-175.
75. West ES, Behrens A, McDonnell PJ, Tielsch J, Schein OD. The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001. Ophthalmology. 2005;112:1388-1394.
76. Clemens TE, Kurinij N, Sperduto RD, AREDS Research Group. Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. Arch Ophthalmol. 2004;122:716-726.
77. Nucci C, Cedrone C, Culasso F, et al. Association between lens opacities and mortality in the Priverno Eye Study. Graefes Arch Clin Exp Ophthalmol. 2004;242:289-294.
78. Williams SL, Ferrigno L, Mora P, Rosmini F, Mariani G. Baseline cataract type and 10-year mortality in the Italian-American Case-Control Study of age-related cataract. Am J Epidemiol. 2002;156:127-131.
79. Wang JJ, Mitchell P, Simpson JM, Cumming RG, Smith W. Visual impairment, age-related cataract, and mortality. Arch Ophthalmol. 2001;119:1186-1190.
80. Hennis A, Wu SY, Li X, et al. Lens opacities and mortality: the Barbados Eye Studies Ophthalmology. 2001;108:498-504.
81. West SK, Munoz B, Istre J, Rubin GS, Friedman SM, Fried LP, Bandeen-Roche K, Schein OD. Mixed lens opacities and subsequent mortality. Arch Ophthalmol. 2000;118:393-397.
82. McGwin G, Owsley C, Gauthreaux S. The association between cataract and mortality among older adults. Ophthalmic Epi. 2003;10:107-119.
83. Gracey RW, Yuksei KU, Jacobsen TM, et al. Cellular models and tissue equivalent systems for evaluating the structures and significance of age modified proteins. Gerontology. 1991;137:113-127.